Payment overview · 2025
General Payments
$42.57
2 reported records · 2 companies
Healthcare provider profile · identity verified
Robert Ted Cook, MD MPH FAAFP
Allopathic & Osteopathic Physicians|Internal Medicine · CHATSWORTH, GA · NPI 1255327052
Verified facts
What the public records show
CMS Open Payments records show Robert Ted Cook, MD MPH FAAFP received $42.57 in general payments during 2025 across 2 reported records.
Medtronic, Inc. accounted for 54.2% of that reported general-payment amount.
The Open Payments records used for this analysis explicitly named 2 associated products.
A separate comparison found the same explicitly named product in public Medicare Part D data: Trelegy Ellipta.
GlaxoSmithKline, LLC. reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported TRELEGY ELLIPTA as an associated drug or biological on 131532 records involving 37148 distinct recipient NPIs. Public Medicare Part D data also shows 190 claims for Trelegy Ellipta by this doctor in 2024.
These records do not establish that a payment influenced prescribing or medical care.
Separate record types
Research & Ownership
Research Payments (direct recipient): not present in the loaded data
Associated Research Funding (for example, named PI): not present in the loaded data
Ownership / Investment: not present in the loaded data
These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.
Who paid this doctor?
Companies in 2025 General Payments
| Reported company | Canonical company | Amount | Share | Records | Year |
|---|---|---|---|---|---|
| Medtronic, Inc. |
Medtronic, Inc. exact · evidence 2025-07-22 |
$23.06 | 54.2% | 1 | 2025 |
| GlaxoSmithKline, LLC. | Unresolved — no canonical attribution shown | $19.51 | 45.8% | 1 | 2025 |
What were the payments for?
Payment categories
| Category | Amount | Records |
|---|---|---|
| Food and Beverage | $42.57 | 2 |
A meal, consulting fee, royalty, and travel payment describe different kinds of reported relationships and should not be interpreted as equivalent.
Analysis 1 · Payment-linked products
Products named in Open Payments records
| Reported product | Type | Reported company | Related amount* | Records | Year |
|---|---|---|---|---|---|
| KYPHON EXPRESS II KYPHOPAK TRAY Normalized: kyphon express ii kyphopak tray |
Device | Medtronic, Inc. | $23.06 | 1 | 2025 |
Source payment records
|
|||||
| TRELEGY ELLIPTA Normalized: trelegy ellipta |
Drug | GlaxoSmithKline, LLC. | $19.51 | 1 | 2025 |
Source payment records
|
|||||
* Product-associated amounts are non-additive because one payment record may name more than one product.
These products were named on specific Open Payments records. A named product does not show that the payment influenced treatment or prescribing.
Public prescribing for products named in payments
| Open Payments product | Payment year | Part D brand | Part D year | Claims | Match method | Source |
|---|---|---|---|---|---|---|
| TRELEGY ELLIPTA trelegy ellipta |
2025 | Trelegy Ellipta | 2024 | 190 | exact normalized | Medicare Part D |
The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.
Analysis 2 · Same-company prescribing overlap
Drugs reported in other payments from the same company that also appear in Medicare Part D
This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.
| Paying company | Payment year | Drug reported by same entity | Open Payments evidence | Part D | Claims | Beneficiaries |
|---|---|---|---|---|---|---|
| GlaxoSmithKline, LLC. Exact reporting entity; no affiliate inference |
2025 | TRELEGY ELLIPTA open payments reported associated product |
CMS Open Payments — General Payments 131532 supporting records · 37148 recipient NPIs · example record 1190332369 |
Trelegy Ellipta · 2024 Exact normalized brand match · 1 Part D row |
190 | 28 |
These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.
Public Medicare Part D data
Provider-and-drug rows loaded for 2024
| Brand | Generic | Claims | Beneficiaries |
|---|---|---|---|
| Levothyroxine Sodium | Levothyroxine Sodium | 783 | 134 |
| Atorvastatin Calcium | Atorvastatin Calcium | 738 | 124 |
| Hydrocodone-Acetaminophen | Hydrocodone/Acetaminophen | 682 | 92 |
| Eliquis | Apixaban | 667 | 57 |
| Omeprazole | Omeprazole | 648 | 110 |
| Gabapentin | Gabapentin | 607 | 86 |
| Amlodipine Besylate | Amlodipine Besylate | 571 | 115 |
| Furosemide | Furosemide | 542 | 96 |
| Sertraline Hcl | Sertraline Hcl | 459 | 55 |
| Potassium Chloride | Potassium Chloride | 403 | 67 |
| Metoprolol Tartrate | Metoprolol Tartrate | 367 | 60 |
| Pantoprazole Sodium | Pantoprazole Sodium | 366 | 82 |
| Metformin Hcl | Metformin Hcl | 360 | 67 |
| Donepezil Hcl | Donepezil Hcl | 342 | 43 |
| Mirtazapine | Mirtazapine | 340 | 52 |
| Losartan Potassium | Losartan Potassium | 330 | 66 |
| Rosuvastatin Calcium | Rosuvastatin Calcium | 321 | 81 |
| Trazodone Hcl | Trazodone Hcl | 307 | 49 |
| Tramadol Hcl | Tramadol Hcl | 304 | 69 |
| Divalproex Sodium | Divalproex Sodium | 297 | 32 |
| Quetiapine Fumarate | Quetiapine Fumarate | 275 | 36 |
| Tamsulosin Hcl | Tamsulosin Hcl | 259 | 36 |
| Lisinopril | Lisinopril | 246 | 56 |
| Metoprolol Succinate | Metoprolol Succinate | 244 | 52 |
| Meloxicam | Meloxicam | 221 | 38 |
| Januvia | Sitagliptin Phosphate | 213 | 26 |
| Simvastatin | Simvastatin | 213 | 50 |
| Lorazepam | Lorazepam | 199 | 35 |
| Buspirone Hcl | Buspirone Hcl | 197 | 34 |
| Trelegy Ellipta | Fluticasone/Umeclidin/Vilanter | 190 | 28 |
| Jardiance | Empagliflozin | 188 | 22 |
| Memantine Hcl | Memantine Hcl | 188 | 24 |
| Clopidogrel | Clopidogrel Bisulfate | 185 | 39 |
| Ropinirole Hcl | Ropinirole Hcl | 175 | 29 |
| Montelukast Sodium | Montelukast Sodium | 174 | 38 |
| Myrbetriq | Mirabegron | 169 | 14 |
| Doxycycline Hyclate | Doxycycline Hyclate | 163 | 109 |
| Duloxetine Hcl | Duloxetine Hcl | 161 | 28 |
| Clonazepam | Clonazepam | 157 | 31 |
| Pravastatin Sodium | Pravastatin Sodium | 155 | 26 |
| Escitalopram Oxalate | Escitalopram Oxalate | 149 | 27 |
| Famotidine | Famotidine | 149 | 32 |
| Albuterol Sulfate Hfa | Albuterol Sulfate | 148 | 46 |
| Carvedilol | Carvedilol | 145 | 31 |
| Tizanidine Hcl | Tizanidine Hcl | 140 | 37 |
| Rexulti | Brexpiprazole | 132 | suppressed |
| Citalopram Hbr | Citalopram Hydrobromide | 128 | 22 |
| Primidone | Primidone | 126 | 12 |
| Levetiracetam | Levetiracetam | 125 | 14 |
| Venlafaxine Hcl Er | Venlafaxine Hcl | 123 | 15 |
| Pregabalin | Pregabalin | 121 | 21 |
| Atenolol | Atenolol | 117 | 27 |
| Ezetimibe | Ezetimibe | 116 | 23 |
| Hydrochlorothiazide | Hydrochlorothiazide | 116 | 24 |
| Basaglar Kwikpen U-100 | Insulin Glargine,hum.Rec.Anlog | 114 | 13 |
| Fluoxetine Hcl | Fluoxetine Hcl | 113 | 12 |
| Spironolactone | Spironolactone | 112 | 21 |
| Allopurinol | Allopurinol | 109 | 23 |
| Torsemide | Torsemide | 109 | 25 |
| Enulose | Lactulose | 107 | suppressed |
| Cefdinir | Cefdinir | 105 | 76 |
| Tradjenta | Linagliptin | 105 | 11 |
| Tresiba Flextouch U-100 | Insulin Degludec | 100 | 15 |
| Olanzapine | Olanzapine | 97 | 11 |
| Baclofen | Baclofen | 95 | 16 |
| Ipratropium-Albuterol | Ipratropium/Albuterol Sulfate | 89 | 29 |
| Fiasp Flextouch | Insulin Aspart (Niacinamide) | 86 | 15 |
| Oxycodone Hcl | Oxycodone Hcl | 85 | 13 |
| Glimepiride | Glimepiride | 83 | 18 |
| Ondansetron Hcl | Ondansetron Hcl | 83 | 37 |
| Mounjaro | Tirzepatide | 79 | suppressed |
| Alprazolam | Alprazolam | 75 | 14 |
| Ciprofloxacin Hcl | Ciprofloxacin Hcl | 74 | 47 |
| Lamotrigine | Lamotrigine | 72 | suppressed |
| Oxycodone-Acetaminophen | Oxycodone Hcl/Acetaminophen | 72 | 12 |
| Ceftriaxone | Ceftriaxone Sodium | 71 | 28 |
| Estradiol | Estradiol | 71 | 18 |
| Ozempic | Semaglutide | 71 | 13 |
| Risperidone | Risperidone | 71 | suppressed |
| Pramipexole Dihydrochloride | Pramipexole Di-Hcl | 70 | suppressed |
| Fluticasone Propionate | Fluticasone Propionate | 69 | 22 |
| Repaglinide | Repaglinide | 69 | 12 |
| Xarelto | Rivaroxaban | 67 | suppressed |
| Ziprasidone Hcl | Ziprasidone Hcl | 65 | suppressed |
| Fluconazole | Fluconazole | 64 | 39 |
| Aripiprazole | Aripiprazole | 63 | 12 |
| Butalbital-Acetaminophen-Caffe | Butalb/Acetaminophen/Caffeine | 63 | suppressed |
| Carbidopa-Levodopa | Carbidopa/Levodopa | 63 | suppressed |
| Latanoprost | Latanoprost | 63 | suppressed |
| Irbesartan | Irbesartan | 61 | 18 |
| Nitrofurantoin Mono-Macro | Nitrofurantoin Monohyd/M-Cryst | 61 | 40 |
| Sulfamethoxazole-Trimethoprim | Sulfamethoxazole/Trimethoprim | 61 | 30 |
| Oxybutynin Chloride Er | Oxybutynin Chloride | 59 | 12 |
| Hydroxyzine Hcl | Hydroxyzine Hcl | 58 | suppressed |
| Breo Ellipta | Fluticasone/Vilanterol | 57 | suppressed |
| Midodrine Hcl | Midodrine Hcl | 55 | suppressed |
| Prednisone | Prednisone | 55 | 22 |
| Cephalexin | Cephalexin | 54 | 34 |
| Benazepril Hcl | Benazepril Hcl | 53 | suppressed |
| Isosorbide Mononitrate Er | Isosorbide Mononitrate | 53 | 11 |
| Levocetirizine Dihydrochloride | Levocetirizine Dihydrochloride | 53 | 11 |
| Alendronate Sodium | Alendronate Sodium | 51 | suppressed |
| Amiodarone Hcl | Amiodarone Hcl | 51 | suppressed |
| Lidocaine Hcl | Lidocaine Hcl | 51 | 29 |
| Promethazine Hcl | Promethazine Hcl | 51 | 15 |
| Finasteride | Finasteride | 50 | 11 |
| Methylprednisolone | Methylprednisolone | 50 | 33 |
| Synthroid | Levothyroxine Sodium | 50 | 12 |
| Dexamethasone Sodium Phosphate | Dexamethasone Sodium Phosphate | 48 | 21 |
| Entresto | Sacubitril/Valsartan | 47 | suppressed |
| Methocarbamol | Methocarbamol | 47 | 12 |
| Azelastine Hcl | Azelastine Hcl | 46 | 15 |
| Oxybutynin Chloride | Oxybutynin Chloride | 45 | suppressed |
| Risperdal Consta | Risperidone Microspheres | 45 | suppressed |
| Bupropion Hcl Sr | Bupropion Hcl | 44 | suppressed |
| Doxycycline Monohydrate | Doxycycline Monohydrate | 44 | 35 |
| Fenofibrate | Fenofibrate Nanocrystallized | 44 | suppressed |
| Fenofibrate | Fenofibrate,micronized | 44 | suppressed |
| Amoxicillin-Clavulanate Potass | Amoxicillin/Potassium Clav | 43 | 36 |
| Sucralfate | Sucralfate | 43 | 11 |
| Trulicity | Dulaglutide | 43 | suppressed |
| Levofloxacin | Levofloxacin | 41 | 29 |
| Propranolol Hcl | Propranolol Hcl | 41 | suppressed |
| Nystatin | Nystatin | 40 | 25 |
| Zolpidem Tartrate | Zolpidem Tartrate | 40 | suppressed |
| Bupropion Xl | Bupropion Hcl | 39 | suppressed |
| Diclofenac Sodium | Diclofenac Sodium | 39 | 13 |
| Mupirocin | Mupirocin | 39 | 19 |
| Paroxetine Hcl | Paroxetine Hcl | 39 | suppressed |
| Hydralazine Hcl | Hydralazine Hcl | 37 | 14 |
| Warfarin Sodium | Warfarin Sodium | 37 | suppressed |
| Triamterene-Hydrochlorothiazid | Triamterene/Hydrochlorothiazid | 36 | suppressed |
| Cholestyramine | Cholestyramine (With Sugar) | 35 | suppressed |
| Fenofibrate | Fenofibrate | 35 | 12 |
| Haloperidol | Haloperidol | 35 | suppressed |
| Metoclopramide Hcl | Metoclopramide Hcl | 35 | suppressed |
| Hydroxyzine Pamoate | Hydroxyzine Pamoate | 34 | suppressed |
| Incruse Ellipta | Umeclidinium Bromide | 34 | suppressed |
| Lactulose | Lactulose | 34 | suppressed |
| Meclizine Hcl | Meclizine Hcl | 34 | 16 |
| Metformin Hcl Er | Metformin Hcl | 34 | suppressed |
| Valacyclovir | Valacyclovir Hcl | 34 | 11 |
| Amoxicillin | Amoxicillin | 32 | 21 |
| Hydrocortisone | Hydrocortisone | 32 | suppressed |
| Amantadine | Amantadine Hcl | 31 | suppressed |
| Lisinopril-Hydrochlorothiazide | Lisinopril/Hydrochlorothiazide | 31 | suppressed |
| Pioglitazone Hcl | Pioglitazone Hcl | 31 | suppressed |
| Risperidone Odt | Risperidone | 31 | suppressed |
| Acetazolamide | Acetazolamide | 30 | suppressed |
| Azithromycin | Azithromycin | 30 | 22 |
| Benztropine Mesylate | Benztropine Mesylate | 30 | suppressed |
| Cyclobenzaprine Hcl | Cyclobenzaprine Hcl | 30 | suppressed |
| Doxazosin Mesylate | Doxazosin Mesylate | 30 | suppressed |
| Olmesartan Medoxomil | Olmesartan Medoxomil | 30 | suppressed |
| Farxiga | Dapagliflozin Propanediol | 29 | suppressed |
| Calcitriol | Calcitriol | 28 | suppressed |
| Ranolazine Er | Ranolazine | 28 | suppressed |
| Amlodipine Besylate-Benazepril | Amlodipine Besylate/Benazepril | 27 | suppressed |
| Clonidine Hcl | Clonidine Hcl | 27 | suppressed |
| Digoxin | Digoxin | 27 | suppressed |
| Ondansetron Odt | Ondansetron | 27 | 17 |
| Brilinta | Ticagrelor | 26 | suppressed |
| Olanzapine Odt | Olanzapine | 26 | suppressed |
| Rybelsus | Semaglutide | 26 | suppressed |
| Briviact | Brivaracetam | 25 | suppressed |
| Ibuprofen | Ibuprofen | 25 | suppressed |
| Ipratropium Bromide | Ipratropium Bromide | 25 | suppressed |
| Glipizide | Glipizide | 24 | suppressed |
| Lantus Solostar | Insulin Glargine,hum.Rec.Anlog | 24 | suppressed |
| Losartan-Hydrochlorothiazide | Losartan/Hydrochlorothiazide | 24 | suppressed |
| Nateglinide | Nateglinide | 24 | suppressed |
| Novolog Flexpen | Insulin Aspart | 24 | suppressed |
| Vascepa | Icosapent Ethyl | 24 | suppressed |
| Vraylar | Cariprazine Hcl | 24 | suppressed |
| Dextroamphetamine-Amphetamine | Dextroamphetamine/Amphetamine | 23 | suppressed |
| Valsartan | Valsartan | 23 | suppressed |
| Fludrocortisone Acetate | Fludrocortisone Acetate | 22 | suppressed |
| Hydroxychloroquine Sulfate | Hydroxychloroquine Sulfate | 22 | suppressed |
| Sulfasalazine | Sulfasalazine | 22 | suppressed |
| Topiramate | Topiramate | 22 | suppressed |
| Toujeo Solostar | Insulin Glargine,hum.Rec.Anlog | 22 | suppressed |
| Carbamazepine | Carbamazepine | 21 | suppressed |
| Namzaric | Memantine Hcl/Donepezil Hcl | 21 | suppressed |
| Raloxifene Hcl | Raloxifene Hcl | 21 | suppressed |
| Albuterol Sulfate | Albuterol Sulfate | 20 | 15 |
| Nitroglycerin | Nitroglycerin | 20 | 13 |
| Dicyclomine Hcl | Dicyclomine Hcl | 19 | suppressed |
| Doxepin Hcl | Doxepin Hcl | 19 | suppressed |
| Dropsafe Prep Pads | Alcohol Antiseptic Pads | 19 | suppressed |
| Clindamycin Hcl | Clindamycin Hcl | 18 | suppressed |
| Galantamine Er | Galantamine Hbr | 18 | suppressed |
| Linzess | Linaclotide | 18 | suppressed |
| Amitriptyline Hcl | Amitriptyline Hcl | 17 | suppressed |
| Colchicine | Colchicine | 17 | suppressed |
| Esomeprazole Magnesium | Esomeprazole Magnesium | 17 | suppressed |
| Memantine Hcl Er | Memantine Hcl | 17 | suppressed |
| Naproxen | Naproxen | 17 | suppressed |
| Soaanz | Torsemide | 17 | suppressed |
| Budesonide-Formoterol Fumarate | Budesonide/Formoterol Fumarate | 16 | suppressed |
| Diltiazem Hcl | Diltiazem Hcl | 16 | suppressed |
| Medroxyprogesterone Acetate | Medroxyprogesterone Acetate | 16 | suppressed |
| Ramipril | Ramipril | 16 | suppressed |
| Ezetimibe-Simvastatin | Ezetimibe/Simvastatin | 15 | suppressed |
| Felodipine Er | Felodipine | 15 | suppressed |
| Testosterone Cypionate | Testosterone Cypionate | 15 | suppressed |
| Tobramycin | Tobramycin | 15 | 12 |
| Triamcinolone Acetonide | Triamcinolone Acetonide | 15 | suppressed |
| Brimonidine Tartrate | Brimonidine Tartrate | 14 | suppressed |
| Desvenlafaxine Succinate Er | Desvenlafaxine Succinate | 14 | suppressed |
| Methimazole | Methimazole | 14 | suppressed |
| Nyamyc | Nystatin | 14 | suppressed |
| Propranolol Hcl Er | Propranolol Hcl | 14 | suppressed |
| Venlafaxine Hcl | Venlafaxine Hcl | 14 | suppressed |
| Carbidopa-Levodopa Er | Carbidopa/Levodopa | 13 | suppressed |
| Cholestyramine Light | Cholestyramine | 13 | suppressed |
| Diltiazem 24hr Er (Cd) | Diltiazem Hcl | 13 | suppressed |
| Metronidazole | Metronidazole | 13 | suppressed |
| Prolensa | Bromfenac Sodium | 13 | suppressed |
| Ventolin Hfa | Albuterol Sulfate | 13 | suppressed |
| Breztri Aerosphere | Budesonide/Glycopyr/Formoterol | 12 | suppressed |
| Bupropion Hcl | Bupropion Hcl | 12 | suppressed |
| Cinacalcet Hcl | Cinacalcet Hcl | 12 | suppressed |
| Daptomycin | Daptomycin | 12 | suppressed |
| Diclofenac Sodium Er | Diclofenac Sodium | 12 | suppressed |
| Fosfomycin Tromethamine | Fosfomycin Tromethamine | 12 | suppressed |
| Gemtesa | Vibegron | 12 | suppressed |
| Insulin Aspart Flexpen | Insulin Aspart | 12 | suppressed |
| Lithium Carbonate Er | Lithium Carbonate | 12 | suppressed |
| Lurasidone Hcl | Lurasidone Hcl | 12 | suppressed |
| Megestrol Acetate | Megestrol Acetate | 12 | suppressed |
| Methenamine Hippurate | Methenamine Hippurate | 12 | suppressed |
| Theophylline Er | Theophylline Anhydrous | 12 | suppressed |
| Anastrozole | Anastrozole | 11 | suppressed |
| Butalb-Acetaminoph-Caff-Codein | Butalbit/Acetamin/Caff/Codeine | 11 | suppressed |
| Celecoxib | Celecoxib | 11 | suppressed |
| Fluticasone-Salmeterol | Fluticasone Propion/Salmeterol | 11 | suppressed |
| Irbesartan-Hydrochlorothiazide | Irbesartan/Hydrochlorothiazide | 11 | suppressed |
| Lovastatin | Lovastatin | 11 | suppressed |
| Prednisolone Acetate | Prednisolone Acetate | 11 | suppressed |
| Tamoxifen Citrate | Tamoxifen Citrate | 11 | suppressed |
| Terazosin Hcl | Terazosin Hcl | 11 | suppressed |
| Tramadol Hcl Er | Tramadol Hcl | 11 | suppressed |
| Ursodiol | Ursodiol | 11 | suppressed |
Timeline
Payment and prescribing data by year
Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.
| Year | General Payments | Main payer | Explicit products | Company overlaps | Part D coverage |
|---|---|---|---|---|---|
| 2025 | $42.57 · 2 records | Medtronic, Inc. | KYPHON EXPRESS II KYPHOPAK TRAY, TRELEGY ELLIPTA | 1 | — |
| 2024 | — | — | — | — | Complete |
Questions to ask
Questions you could discuss with your doctor
- What role, if any, does Trelegy Ellipta play in your treatment recommendations for me?
- How do you evaluate evidence when you have a financial relationship with GlaxoSmithKline, LLC.?
- Are there reasonable alternatives I should understand when we discuss treatment options?
- How should I interpret the industry-payment records shown here in the context of my care?
These are general questions generated from reviewed templates. They are not personalized medical advice.
Sources and limitations
How to read this page
- Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
- Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
- Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
- Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
- When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.
Loaded source releases
| Dataset | Year | Publication | Source |
|---|---|---|---|
| CMS Open Payments — General Payments | 2025 | 2026-06-30 | Original source |
| Medicare Part D Prescribers by Provider and Drug | 2024 | 2026-05-06 | Original source |
| NPPES Data Dissemination V2 | current / reference data | 2026-08-10 | Original source |
Full methodology · Questions & answers · Report a possible error